| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Abernathy James Paul serves as a Director at NHC. Across recent SEC filings that breaks down to 1 buy and 18 sells. Those positions are worth an estimated $8.7M at current prices.
Historically, Abernathy James Paul's trades have earned a below-average insider score of 47/100 across 3 rated trades. Over a 12-month horizon, 66.7% of those trades were profitable, with an average 12-month return of -3.9%.
The biggest single holding is NHC (~$8.7M) as Director. The recent filings there lean toward selling, a net 16,002 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 7, 2016 | NHC National Healthcare Corp | Director | Sell | 879 | $70.49 | $61,960.71 | -3.8% | |
| Nov 25, 2016 | NHC National Healthcare Corp | Director | Sell | 1,000 | $70.00 | $70,000.00 | -4.1% | |
| Nov 18, 2016 | NHC National Healthcare Corp | Director | Sell | 1,000 | $69.44 | $69,440.00 | -4.0% | |
| Nov 30, 2015 | NHC National Healthcare Corp | Director | Sell | 1,000 | $67.00 | $67,000.00 | -2.3% | |
| Jun 3, 2015 | NHC National Healthcare Corp | Director | Sell | 898 | $63.50 | $57,023.00 | -4.5% | |
| Jun 1, 2015 | NHC National Healthcare Corp | Director | Sell | 102 | $63.51 | $6,478.50 | -0.3% | |
| May 28, 2015 | NHC National Healthcare Corp | Director | Sell | 1,310 | $63.00 | $82,530.00 | -6.2% |